Lisdexamphetamine versus methylphenidate for paediatric patients with attention-deficit hyperactivity disorder and type 1 diabetes (LAMAinDiab): protocol for a multicentre, randomised cross-over clinical trial in an outpatient telemedicine-supported setting.

Introduction: Attention deficit hyperactivity disorder (ADHD) affects 5%-10% of paediatric population and is reportedly more common in children with type 1 diabetes (T1D), exacerbating its clinical course. Proper treatment of ADHD in such patients may thus provide neurological and metabolic benefits. To test this, we designed a non-commercial second phase clinical trial comparing the impact of different pharmacological interventions for ADHD in children with T1D.

Assessment of Selected Aspects of the Quality of Life of Children with Type 1 Diabetes Mellitus in Poland.

Type 1 diabetes mellitus (T1D) is, next to obesity and asthma, the most common chronic disease in children in Poland. T1D is not only a medical challenge, but it also affects all areas of a sick child's life and family functionality. New forms of therapy facilitate the daily management of the disease, but their availability is limited and partly dependent on socioeconomic status.

The degree of fathers' involvement in taking care of children with diabetesand its implications in family functioning in the assessment of diabetic children's mothers.

Introduction: Children's type 1 diabetes is one of the most mentally aggravating chronic diseases for the patient and his/her parents. The disease disturbs relationships in the family, disrupts communication, and enforces a change in the organisation of daily life.

The Aim Of The Study: The aim of the study was to gather opinions about fathers' involvement in taking care of children with type 1 diabetes.